Objective To compare the clinical effects of radiofrequency ablation (RFA) and percutaneous ethanol injection (PEI) in treating postoperative recurrence of hepatocellular carcinoma (HCC) and to provide reference for clinical treatment of recurrent HCC. Methods A retrospective analysis was performed on the clinical data of 175 patients who had a single recurrent lesion after surgical treatment of HCC from August 2007 to January 2010. These patients were divided into PEI group (n=101) and RFA group (n=74) according to the modalities of treatment for recurrent HCC. All cases underwent color Doppler ultrasound and contrast-enhanced ultrasound or CT before and after treatment. The two groups were compared in terms of number of treatments, complete ablation rate, and complication rate. The 1-, 2-, and 3-year survival rates after treatment were also recorded. The measurement data were subjected to t-test, while the enumeration data were subjected to chi-square test. Results The PEI group had a significantly larger mean number of treatments than the RFA group (P<0.05). There was no significant difference in complication rate between the two groups (P>0.05). For the recurrent lesions smaller than 2.0 cm in diameter, the complete ablation rate showed no significant difference between the RFA group and PEI group (P>0.05), while this rate was significantly higher in the RFA group than in the PEI group for the recurrent lesions with a diameter of 2.0-5.0 cm (P<005). Among the patients with recurrent lesions smaller than 2.0 cm in diameter, those receiving PEI had 1-, 2-, and 3-year survival rates of 89.1%, 69.1%, and 49.1%, respectively, versus 90.2%, 70.7%, and 53.7% for those receiving RFA (P>0.05); among the patients with recurrent lesions with a diameter of 2.0-5.0 cm, those receiving PEI had significantly lower 1-, 2-, and 3-year survival rates than those receiving RFA (63.0% vs 84.8%, P<0.05; 43.5% vs 66.7%, P<0.05; 21.7% vs 45.5%, P<0.05). Conclusion RFA and PEI lead to similar survival rates in patients with recurrent lesions smaller than 2.0 cm in diameter after surgical treatment of HCC, but RFA produces a better survival than PEI in those with recurrent lesions with a diameter of 2.0-5.0 cm.
丁 红 马力文 王 东 王 艳 王 甦 石 军 吕云福 吕洪敏 朱风尚 朱向高 朱 英
朱宝和 朱晓黎 任建庄 刘 珏 刘 梅 祁兴顺 许翠萍 孙 捷 杜奕奇 杜端明 李长政
李 君 李建军 李俊峰 李桂英 李 海 杨 田 杨 丽 杨 松 吴德全 别 平 何卫平
张 权 张成武 张春清 张跃伟 张缭云 陆忠华 陈平圣 陈 刚 陈 钟 林潮双 尚 东
周 琳 郑进方 郑瑞丹 赵雪珂 郝建宇 钟晓刚 徐有青 徐洪雨 郭闻渊 崔石昌 阎 明
梁志海 彭向欣 董育炜 程书权 程 朋 曾庆磊 曾 珍 曾维政 谢正元 廖柏明 樊艳华
戴二黑